Literature DB >> 6321795

Encephalitis resulting from reactivation of latent herpes simplex virus in mice.

T Sekizawa, H Openshaw.   

Abstract

Herpes simplex virus (HSV) encephalitis was produced in mice from reactivation of latent virus. Two experimental models were used: the trigeminal model after corneal inoculation of HSV, and the hypoglossal model after tongue inoculation of HSV. In the trigeminal model, cyclophosphamide treatment induced reactivation of latent virus in ganglia but not in central nervous system tissue. Spread of the reactivated virus from ganglia to brain occurred only in mice deficient in anti-HSV antibody. In the hypoglossal model, sectioning of the hypoglossal nerve provoked chromatolysis in the corresponding central nervous system motor neurons and occasionally reactivated latent HSV in the brains of mice. These results suggest that HSV encephalitis can result from the spread of reactivated virus from ganglia to brain and also from in situ reactivation in brain.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6321795      PMCID: PMC255608     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

1.  Reactivation of herpes simplex virus (type 2) infection in trigeminal ganglia and oral lips with cyclophosphamide treatment.

Authors:  T Kurata; K Kurata; Y Aoyama
Journal:  Jpn J Exp Med       Date:  1978-10

2.  Temperature-sensitive mutants of herpes simplex virus differ in the capacity to establish latent infections in mice.

Authors:  K W Lofgren; J G Stevens; H S Marsden; J H Subak-Sharpe
Journal:  Virology       Date:  1977-01       Impact factor: 3.616

3.  Recovery of herpes-simplex virus from human trigeminal ganglions.

Authors:  J R Baringer; P Swoveland
Journal:  N Engl J Med       Date:  1973-03-29       Impact factor: 91.245

4.  Latent herpes simplex virus in spinal ganglia of mice.

Authors:  J G Stevens; M L Cook
Journal:  Science       Date:  1971-08-27       Impact factor: 47.728

5.  Dna restriction-enzyme analysis of herpes simplex virus isolates obtained from patients with encephalitis.

Authors:  R Whitley; A D Lakeman; A Nahmias; B Roizman
Journal:  N Engl J Med       Date:  1982-10-21       Impact factor: 91.245

6.  Acute and latent infection of sensory ganglia with herpes simplex virus: immune control and virus reactivation.

Authors:  H Openshaw; L V Asher; C Wohlenberg; T Sekizawa; A L Notkins
Journal:  J Gen Virol       Date:  1979-07       Impact factor: 3.891

7.  Herpesvirus hominis: isolation from human trigeminal ganglion.

Authors:  F O Bastian; A S Rabson; C L Yee; T S Tralka
Journal:  Science       Date:  1972-10-20       Impact factor: 47.728

8.  Latency of herpes simplex virus in absence of neutralizing antibody: model for reactivation.

Authors:  T Sekizawa; H Openshaw; C Wohlenberg; A L Notkins
Journal:  Science       Date:  1980-11-28       Impact factor: 47.728

9.  Herpes simplex type 1 DNA in human brain tissue.

Authors:  N W Fraser; W C Lawrence; Z Wroblewska; D H Gilden; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

10.  Latent herpes simplex virus in the central nervous system of rabbits and mice.

Authors:  F B Knotts; M L Cook; J G Stevens
Journal:  J Exp Med       Date:  1973-09-01       Impact factor: 14.307

View more
  14 in total

1.  Herpes simplex virus, type 1 invasion of the rabbit and mouse nervous systems revealed by in situ hybridization.

Authors:  W G Stroop; D C Schaefer
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

2.  Idiopathic third cranial nerve palsy associated with herpes simplex virus infection.

Authors:  T Sekizawa; S Nakamura; K Kogure; K Hayashi; K Yanagi; H Openshaw
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-03

3.  Autonomic nervous system involvement in experimental genital infection by herpes simplex virus type 2.

Authors:  N A Sanjuan; E F Lascano
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

4.  Role of antibody in primary and recurrent herpes simplex virus infection.

Authors:  A Simmons; A A Nash
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

5.  Upregulation of mouse genes in HSV-1 latent TG after butyrate treatment implicates the multiple roles of the LAT-ICP0 locus.

Authors:  Christian Clement; Partha S Bhattacharjee; Manish Kumar; Timothy P Foster; Hilary W Thompson; James M Hill
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-28       Impact factor: 4.799

6.  Efficient reactivation of latent herpes simplex virus from mouse central nervous system tissues.

Authors:  Shih-Heng Chen; Hui-Wen Yao; Wen-Yen Huang; Kuei-Sen Hsu; Huan-Yao Lei; Ai-Li Shiau; Shun-Hua Chen
Journal:  J Virol       Date:  2006-09-27       Impact factor: 5.103

7.  In vivo reactivation of latent herpes simplex virus 1 in mice can occur in the brain before occurring in the trigeminal ganglion.

Authors:  Hui-Wen Yao; Pin Ling; Yuk-Ying Tung; Sheng-Min Hsu; Shun-Hua Chen
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

8.  Selective vulnerability of mouse CNS neurons to latent infection with a neuroattenuated herpes simplex virus-1.

Authors:  S Kesari; V M Lee; S M Brown; J Q Trojanowski; N W Fraser
Journal:  J Neurosci       Date:  1996-09-15       Impact factor: 6.167

Review 9.  Directional spread of alphaherpesviruses in the nervous system.

Authors:  Tal Kramer; Lynn W Enquist
Journal:  Viruses       Date:  2013-02-11       Impact factor: 5.048

Review 10.  Herpes simplex virus infects most cell types in vitro: clues to its success.

Authors:  Ghadah A Karasneh; Deepak Shukla
Journal:  Virol J       Date:  2011-10-26       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.